Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
J Perinatol ; 32(8): 621-5, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22076414

RESUMO

OBJECTIVE: Candida infections cause substantial morbidity and mortality in neonates. Persistent candidemia has not been associated with increased risk of mortality compared with candidemia of shorter duration. This study sought to determine whether persistent candidemia was associated with increased length of hospitalization or mortality in neonates. STUDY DESIGN: A chart review was conducted of neonates with Candida bloodstream infections (n=37). Demographic, laboratory, pharmacy, nutrition and discharge data were abstracted. Contingency table analysis and logistic regression were used to analyze variables associated with persistent candidemia and mortality. The relationship between length of hospitalization and persistent candidemia was assessed with k-sample equality of medians test. RESULT: Nine patients (24%) had persistent candidemia. Increased time between blood culture draw and initial antifungal therapy was associated with increased incidence of persistent candidemia (P=0.03). Five patients (14%) died before hospital discharge; however, no deaths were attributed to persistent candidemia. Length of hospitalization was not increased with persistent candidemia. A decrease in the ratio of enteral feeding days to hyperalimentation days before collection of the first positive blood culture was significantly associated with an increase in all-cause mortality (P=0.03) and death attributed to candidemia (P=0.04). The risk of all-cause mortality decreased with a history of receiving any enteral feedings before the first positive blood culture (P=0.04), as did death attributed to candidemia (P=0.02). CONCLUSION: A duration of >1 day between the time of blood culture and the initial dose of systemic antifungal treatment places neonates at increased risk for developing persistent candidemia; however, this is not associated with increased mortality.


Assuntos
Candidemia/mortalidade , Hospitalização/estatística & dados numéricos , Antifúngicos/uso terapêutico , Peso ao Nascer , Candidemia/tratamento farmacológico , Idade Gestacional , Humanos , Recém-Nascido , Unidades de Terapia Intensiva Neonatal , Tempo de Internação/estatística & dados numéricos , Modelos Logísticos , Estudos Retrospectivos , Fatores de Risco , Tempo para o Tratamento
2.
Biol Neonate ; 76(2): 125-8, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10393998

RESUMO

Newborns possess an altered immune response to infection with impaired leukocyte chemotaxis and deficient production of gamma-interferon (IFN-gamma). IFN-gamma enhances neonatal leukocyte activation and movement. We proposed that IFN-gamma in conjunction with penicillin compared to penicillin therapy without IFN-gamma would increase survival from group B streptococcal sepsis in a neonatal rat model. Newborn rats were infected with 10(5) cfu of group B streptococci at 48-72 h of age and randomized to receive either serum albumin (controls), rat recombinant IFN-gamma, albumin and penicillin, or IFN-gamma and penicillin. Survival 120 h postinfection revealed: controls 5% (1/21); IFN-gamma 4% (1/24); penicillin 23% (5/22); and IFN-gamma plus penicillin 10% (2/21). Survival analysis with a lognormal parametric regression model revealed only the penicillin group to have improved survival compared to controls. Contrasting the penicillin group with the IFN-gamma plus penicillin group did not reveal a statistically significant difference by the Wald chi2 statistic (p = 0.25).


Assuntos
Animais Recém-Nascidos , Bacteriemia/terapia , Interferon gama/uso terapêutico , Infecções Estreptocócicas/mortalidade , Infecções Estreptocócicas/terapia , Streptococcus agalactiae , Animais , Bacteriemia/mortalidade , Interferon gama/administração & dosagem , Penicilinas/administração & dosagem , Penicilinas/uso terapêutico , Ratos , Ratos Sprague-Dawley , Proteínas Recombinantes , Taxa de Sobrevida
3.
Pediatr Infect Dis J ; 17(6): 447-52, 1998 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9655532

RESUMO

OBJECTIVE: To determine the efficacy of azithromycin in the treatment of patients with typical cat-scratch disease. DESIGN: Prospective, randomized, double blind, placebo-controlled clinical trial. SETTING: Large military medical center and its referring clinics. PATIENTS: Active duty military members and their dependents with laboratory-confirmed, clinically typical cat-scratch disease. INTERVENTION: Study participants assigned by randomization to treatment with oral azithromycin or placebo for 5 days. OUTCOME MEASURES: Lymph node volume was calculated using three dimensional ultrasonography at entry and at weekly intervals. The ultrasonographer was blinded to the treatment groups. Endpoint evaluations were predetermined as time in days to 80% resolution of the initial total lymph node volume. RESULTS: Demographic and clinical data showed that the azithromycin and placebo treatment groups were comparable at entry although the placebo group tended to be older. Eighty percent decrease of initial lymph node volume was documented in 7 of 14 azithromycin-treated patients compared with 1 of 15 placebo-treated controls during the first 30 days of observation (P = 0.026). After 30 days there was no significant difference in rate or degree of resolution between the two groups. CONCLUSIONS: Treatment of patients with typical cat-scratch disease with oral azithromycin for five days affords significant clinical benefit as measured by total decrease in lymph node volume within the first month of treatment.


Assuntos
Antibacterianos/uso terapêutico , Azitromicina/uso terapêutico , Bartonella henselae , Doença da Arranhadura de Gato/tratamento farmacológico , Adolescente , Adulto , Criança , Método Duplo-Cego , Feminino , Humanos , Modelos Logísticos , Linfonodos/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Ultrassonografia
4.
Pediatr Infect Dis J ; 17(4): 271-7; discussion 277-9, 1998 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9576380

RESUMO

BACKGROUND: The management of young children with fever without source is controversial, and differences between physician specialties have been noted previously. The emergence of penicillin-resistant Streptococcus pneumoniae, the sharp decline in invasive Haemophilus influenzae infections in immunized populations and publication of practice guidelines have potentially altered physician practices. OBJECTIVE: To determine the present practice preferences of pediatricians, family medicine physicians (FP) and emergency medicine physicians (EP). METHODS: We mailed a checklist survey to 1600 randomly selected pediatricians, family medicine practitioners (FP) and emergency medicine physicians (EP) in the United States and replicated the methodology of a 1991/1992 survey. Physicians were asked about their evaluation and management of children of various ages (3 weeks, 7 weeks, 4 months and 16 months) with fever without source. RESULTS: Most primary care physicians would admit the 3- and 7-week-old infants. For the 4-month-old infant 59% of EP, 45% of pediatricians and 28% of FP would give empiric antibiotic(s) as an outpatient (P=0.005 for FP compared with pediatricians and P=0.02 for EP compared with pediatricians). The majority of physicians would manage the 16-month-old child as an outpatient without antibiotic therapy. Ceftriaxone was the preferred antibiotic for outpatient empiric therapy. There was a 3-fold increase (28% vs. 9%) for pediatricians in the use of empiric outpatient antibiotics for the 7-week-old infant in the present survey compared with the 1991/1992 survey. CONCLUSIONS: Physicians in the United States generally agree in their management of the young febrile infant, but with increasing patient age there is considerable variation. FP were the least aggressive in their evaluation and EP were the most aggressive.


Assuntos
Medicina de Emergência , Medicina de Família e Comunidade , Febre de Causa Desconhecida/diagnóstico , Febre de Causa Desconhecida/terapia , Pediatria , Padrões de Prática Médica/estatística & dados numéricos , Antibacterianos/uso terapêutico , Febre de Causa Desconhecida/tratamento farmacológico , Pesquisas sobre Atenção à Saúde , Humanos , Lactente , Recém-Nascido , Admissão do Paciente , Guias de Prática Clínica como Assunto , Inquéritos e Questionários
5.
Clin Diagn Lab Immunol ; 3(5): 527-32, 1996 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8877130

RESUMO

Gamma interferon (IFN-gamma) has multiple immunomodulating effects and has been postulated as a possible immunopotentiating agent for the prevention or treatment of neonatal infections. This report describes the effect of rat recombinant IFN-gamma on the oxidative burst activity and CD11b expression of neonatal and adult rat polymorphonuclear leukocytes (PMNL). Oxidative burst activity was assessed by chemiluminescence and dihydrorhodamine flow cytometry. Neonatal PMNL exhibited significantly less oxidative burst activity than did adult PMNL. IFN-gamma mildly enhanced the chemiluminescence response of PMNL from both the rat pups and adults, but this effect was not statistically significant when analyzed by a multivariate model of repeated-measures analysis of variance for both chemiluminescence and dihydrorhodamine flow cytometry. CD11b expression was also not significantly enhanced by IFN-gamma.


Assuntos
Interferon gama/farmacologia , Neutrófilos/efeitos dos fármacos , Animais , Animais Recém-Nascidos , Células Cultivadas , Citometria de Fluxo , Medições Luminescentes , Antígeno de Macrófago 1/biossíntese , Neutrófilos/metabolismo , Ratos , Ratos Sprague-Dawley , Proteínas Recombinantes/farmacologia , Explosão Respiratória/efeitos dos fármacos
7.
Clin Pediatr (Phila) ; 34(3): 122-7, 1995 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-7774137

RESUMO

The potential impact of using a rapid diagnostic test (Strep A OIA) on detection and treatment of group A beta-hemolytic streptococcal (GABHS) pharyngitis in a large-volume pediatric and adolescent clinic was examined. Of 519 swabs processed for both culture and the OIA test, 114 were culture-positive for GABHS compared with 133 positive by the OIA test, for an agreement of 94%. OIA test sensitivity compared with culture was 96%, and specificity was 94%. Forty-seven percent of all study patients were empirically placed on antibiotics. In-clinic OIA testing could have reduced inappropriate therapy and been a cost-effective alternative to culture.


Assuntos
Faringite/microbiologia , Infecções Estreptocócicas , Streptococcus pyogenes/isolamento & purificação , Adolescente , Antibacterianos/uso terapêutico , Técnicas Bacteriológicas , Criança , Pré-Escolar , Custos e Análise de Custo , Meios de Cultura , Humanos , Imunoensaio/métodos , Faringite/tratamento farmacológico , Faringite/economia , Sensibilidade e Especificidade
9.
Pediatr Infect Dis J ; 12(6): 466-73, 1993 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8345978

RESUMO

This prospective multicenter study was conducted to define more clearly clinical and laboratory criteria that predict a strong probability of occult bacteremia and to evaluate the effect of empiric broad spectrum antimicrobial treatment of these children. Children 3 to 36 months old with fever > or = 40 degrees C (104 degrees F) or, > or = 39.5 degrees C (103 degrees F) with white blood cells (WBC) > or = 15 x 10(9)/liter, and no focus of infection had blood cultures obtained and were randomized to treatment with oral amoxicillin/potassium clavulanate or intramuscular ceftriaxone. Sixty of 519 (11.6%) study patients had positive blood cultures: Streptococcus pneumoniae, 51; Haemophilus influenzae b, 6; Neisseria meningitidis, 2; and Group B Streptococcus, 1. Subgroups of high risk were identified as fever > or = 39.5 degrees C and WBC > or = 15 x 10(9)/liter, 55 of 331 or 16.6% positive with increasing incidence of positive culture with increasing increments of degrees of leukocytosis to WBC > or = 30 x 10(9)/liter where 9 of 21 or 42.9% were positive. Subgroups of significantly lower risk were identified as fever > or = 39.5 degrees C and WBC < 15 x 10(9)/liter, 5 of 182 or 2.7% positive and those with WBC < 10 x 10(9)/liter, 0 of 99 or 0.0% positive. Children with positive cultures who received ceftriaxone were nearly all afebrile after 24 hours whereas a significant number who received amoxicillin/potassium clavulanate remained febrile. In the 459 culture-negative children more amoxicillin/potassium clavulanate-treated children developed diarrhea and had less improvement in clinical scores after 24 hours than ceftriaxone-treated children.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Amoxicilina/uso terapêutico , Antibacterianos/uso terapêutico , Bacteriemia/tratamento farmacológico , Ceftriaxona/uso terapêutico , Ácidos Clavulânicos/uso terapêutico , Administração Oral , Amoxicilina/administração & dosagem , Combinação Amoxicilina e Clavulanato de Potássio , Antibacterianos/administração & dosagem , Ceftriaxona/administração & dosagem , Pré-Escolar , Ácidos Clavulânicos/administração & dosagem , Quimioterapia Combinada/administração & dosagem , Quimioterapia Combinada/uso terapêutico , Feminino , Febre , Seguimentos , Infecções por Haemophilus/tratamento farmacológico , Humanos , Lactente , Injeções Intramusculares , Leucocitose , Masculino , Infecções Meningocócicas/tratamento farmacológico , Análise Multivariada , Infecções Pneumocócicas/tratamento farmacológico , Estudos Prospectivos , Análise de Regressão , Resultado do Tratamento
11.
Health Phys ; 62(1): 16-28, 1992 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-1727408

RESUMO

Fallout distributions are calculated for nuclear attacks on the contiguous United States. Four attack scenarios are treated, including counterforce and counterforce-countervalue attacks, for meteorological conditions associated with a typical day in summer and one in winter. The countervalue attacks contain mostly airbursts. To determine fallout effects, the population surviving the prompt effects is first calculated. For the prompt effects, a "conflagration-type" model is used. The counterforce attack produces about 8 million prompt deaths, and the counterforce-countervalue case projects 98 million prompt deaths. Partial relocation before attack to low-risk fallout areas at least 15 km from potential strategic targets would result in a decrease in projections of deaths by tens of millions. For fallout risk calculations, only the dose received in the first 48 h (the early or local fallout) is considered. Populations are assumed to be sheltered, with a shelter protection factor profile that varies for a large urban area, a small urban area, or a rural area. With these profiles, without relocation, the fallout fatalities for all four attack scenarios are calculated to be less than one million people. This can be compared to fallout fatalities of about 10 million for a hypothetical unsheltered "phantom" population.


Assuntos
Guerra Nuclear , Cinza Radioativa , Humanos , Modelos Teóricos , Lesões por Radiação/mortalidade , Risco , População Rural , Estados Unidos , População Urbana
12.
Pediatrics ; 88(5): 1024-30, 1991 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1945606

RESUMO

Due to the dramatic upsurge in the incidence of measles, the American Academy of Pediatrics and the Immunization Practices Advisory Committee of the Centers for Disease Control revised their measles immunization policies in 1989 to include a routine two-dose schedule. The objectives of this study were the following: (1) determine the prevalence of immunologically measles-susceptible subjects in a previously vaccinated, school-age, military dependent population; and (2) assess risk factors to identify immunologically measles-susceptible subjects. Serum was collected just prior to measles revaccination and again 2 weeks later. Measles-specific IgG and IgM titers were determined by enzyme-linked immunosorbent assay. Immunologically measles-susceptible subjects constituted 9.8% of the population. The interval since previous measles vaccination was significantly related to pre- and postrevaccination IgG titers in a repeated-measures analysis of variance model. The magnitude of increase in IgG titer following revaccination and analysis of trend for proportions of measles-susceptible subjects were significantly related to the age of initial vaccination. This study supports continued measles revaccination; in addition, revaccination appears to be of greater value at 11 to 12 years of age than at 4 to 6 years of age.


Assuntos
Vacina contra Sarampo/imunologia , Sarampo/prevenção & controle , Adolescente , Adulto , Análise de Variância , Anticorpos Antivirais/sangue , Criança , Pré-Escolar , Suscetibilidade a Doenças , Combinação de Medicamentos , Ensaio de Imunoadsorção Enzimática , Humanos , Imunização Secundária , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Vacina contra Sarampo-Caxumba-Rubéola , Vacina contra Caxumba/imunologia , Vacina contra Rubéola/imunologia
13.
Am J Dis Child ; 144(12): 1313-5, 1990 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2244610

RESUMO

We attempted to determine the causative bacterial pathogens of impetigo in children in our area, to compare the effectiveness of three frequently used oral antimicrobial treatment regimens, and to correlate the antimicrobial sensitivity of the bacterial isolates with clinical responses to treatment. Seventy-three children with impetigo were randomly assigned to receive penicillin V potassium or cephalexin monohydrate, both administered in dosages of 40 to 50 mg/kg per day, or erythromycin estolate administered in a dosage of 30 to 40 mg/kg per day. All drugs were given in three divided doses for 10 days. Treatment failure was defined as persistence of lesions 8 to 10 days after initiation of drug therapy as determined by examiners blinded to the treatment therapies. Forty-five (62%) cultures showed Staphylococcus aureus only, 14 (19%) showed S aureus and group A beta-hemolytic streptococci, six (8%) showed group A beta-hemolytic streptococci only, and eight (11%) showed no growth or other organisms. Treatment failure occurred in six (24%) of 25 patients treated with penicillin V, one (4%) of 25 patients treated with erythromycin estolate, and no patients treated with cephalexin. We conclude that S aureus is the most common cause of impetigo in children in our study population, that cephalexin is the most effective treatment, that erythromycin estolate is nearly equally effective and may be preferred on a cost-effectiveness basis, and that penicillin V is inadequate for treatment of this infection.


Assuntos
Cefalexina/uso terapêutico , Eritromicina/uso terapêutico , Impetigo/tratamento farmacológico , Penicilinas/uso terapêutico , Infecções Estafilocócicas/tratamento farmacológico , Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Impetigo/microbiologia , Lactente , Masculino , Testes de Sensibilidade Microbiana , Distribuição Aleatória , Infecções Estreptocócicas/tratamento farmacológico
14.
Am J Dis Child ; 144(5): 587-9, 1990 May.
Artigo em Inglês | MEDLINE | ID: mdl-2184661

RESUMO

Penicillin remains the drug of choice for the treatment of streptococcal pharyngitis, with erythromycin as an alternative drug for individuals who cannot take penicillin. Two areas of concern in the management of streptococcal pharyngitis are (1) the prevalence of penicillin-tolerant group A beta-hemolytic streptococci reported in recent studies and (2) the high prevalence of erythromycin resistance in some geographic areas. We tested 305 isolates of group A beta-hemolytic streptococci from Hawaii and the Philippines for penicillin minimum inhibitory concentrations and minimum bactericidal concentrations and erythromycin minimum inhibitory concentrations. There was no evidence of penicillin resistance or tolerance. The prevalence of erythromycin-resistant and moderately susceptible isolates was 3.6% and 2.3%, respectively. There was a trend toward greater erythromycin resistance levels among Hawaiian isolates, but this was not statistically significant.


Assuntos
Eritromicina/farmacologia , Resistência às Penicilinas , Streptococcus pyogenes/efeitos dos fármacos , Resistência Microbiana a Medicamentos , Havaí , Humanos , Militares , Filipinas , Especificidade da Espécie
15.
Pediatr Infect Dis J ; 8(6): 364-7, 1989 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2664692

RESUMO

Antimicrobial treatment of nontyphoidal Salmonella gastroenteritis is usually advocated for infants younger than 3 months of age based on published data showing that infants in this age group are more prone to have bacteremia and develop extraintestinal focal infections. A review of nontyphoidal Salmonella isolates from our institution from January, 1981, through March, 1988, was undertaken to assess the role of age and specific serovar on the incidence of bacteremia. Two hundred twenty isolates were identified: one cerebrospinal fluid, 14 blood and 205 stool. The mean age of patients with bacteremia was 182 months, not significantly different from the mean age of 142 months for patients with stool isolates. Salmonella weltevreden was the most frequent isolate accounting for 23% of all isolates and all isolates of this organism were from stool cultures. Patients with S. weltevreden infections had mean and median ages of 50 and 2.5 months and were younger than patients with stool isolates from other serovars who had mean and median ages of 174 and 38 months. Infants younger than 3 or 6 months of age with positive stool cultures in whom blood cultures were obtained did not demonstrate a higher incidence of bacteremia than did older patients. We conclude that the incidence of bacteremia in patients with nontyphoidal Salmonella gastroenteritis is highly related to the invasiveness of the infecting specific Salmonella serovar.


Assuntos
Gastroenterite/epidemiologia , Infecções por Salmonella/epidemiologia , Sepse/epidemiologia , Adolescente , Antibacterianos/uso terapêutico , Criança , Pré-Escolar , Gastroenterite/tratamento farmacológico , Gastroenterite/microbiologia , Humanos , Lactente , Salmonella/isolamento & purificação , Infecções por Salmonella/tratamento farmacológico , Infecções por Salmonella/microbiologia , Salmonella enteritidis/isolamento & purificação , Sepse/tratamento farmacológico , Sepse/microbiologia
17.
Adv Exp Med Biol ; 169: 793-9, 1984.
Artigo em Inglês | MEDLINE | ID: mdl-6428182

RESUMO

Oxygen profiles were measured polarographically with micro-needle electrodes in single fixed pellets of Penicillium chrysogenum. The oxygen concentration, the grade of turbulence and the flow conditions of the outer medium were varied. Pellets were then histologically investigated. Under our experimental conditions the pellets were found to contain a 200 micrometers thick active outer zone with intact cells. In this zone, the oxygen partial pressure decreased from the initial values to zero. The results show that the Po2 profile within the pellet is strongly influenced by the Po2 of the outer medium. Apart from molecular diffusion, surface turbulence as well as a convective flow through the pellets are of importance for the oxygen transport.


Assuntos
Consumo de Oxigênio , Penicillium chrysogenum/metabolismo , Penicillium/metabolismo , Difusão , Penicillium chrysogenum/crescimento & desenvolvimento
20.
J Bacteriol ; 99(1): 341-3, 1969 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-4979445

RESUMO

Deoxyribonucleic acid base compositions were determined for 25 Mycoplasma strains and 6 L-phase variant strains. Values obtained correlated well with the results of other investigators.


Assuntos
DNA Bacteriano/análise , Formas L/análise , Mycoplasma/análise , Corynebacterium/análise , Enterococcus faecalis/análise , Temperatura Alta , Desnaturação de Ácido Nucleico , Staphylococcus/análise , Streptobacillus/análise , Streptococcus/análise , Streptococcus pyogenes/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...